A Diversified Cannabis Company

Emerald Health Sciences (EHS) is a diversified cannabis company positioned to take advantage of the significant projected growth in different segments of the cannabis industry.

The target segments are Pharmaceuticals, Botanicals (Medical and Recreational), and Nutraceuticals. Each investment leverages the scientific rigor, federal regulatory compliance, and life-science expertise of Emerald Health Sciences’ leadership.

Read More
Investing in multiple industry segments
Emerald Health Pharmaceuticals (EHP)
The Pharmaceutical Division

Is developing two proprietary molecules derived from Cannabidiol (CBD) and Cannabigerol (CBG) for the treatment of Multiple Sclerosis and Scleroderma.

Read More
Emerald Health Botanicals (EHB)
The Pharmaceutical Division

Produces and sells cannabis and oils under federal license from Health Canada.

Read More
Emerald Health Nutraceuticals (EHN)
The Pharmaceutical Division

Develops proprietary formulations that stimulate the Endocannabinoid system for sale in the U.S.

Read More
Preparing for the World’s Largest Legal Market for Recreational Cannabis

Canada’s current government has promised to legalize and regulate recreational cannabis and to introduce new legislation to that end in spring 2017. EHB is gearing up its production in preparation for the potential explosive growth in the market when cannabis is legalized in Canada.

Read More
Meet our team

Emerald Health Sciences’ management integrates extensive experience in building successful life-science companies, industry-leading scientific expertise, and compliance with all applicable international and federal legislation to develop new drugs and products.

Read More
Leadership in Cannabis Science

The world’s top researchers in cannabinoid science are guiding Emerald Health’s Drug Discovery and Drug Development programs.

Read More
news Emerald Milestones & News

Track Emerald’s Milestones and get the latest Emerald News.